Literature DB >> 21681859

CC chemokine ligand 2 and leukemia inhibitory factor cooperatively promote pluripotency in mouse induced pluripotent cells.

Yuki Hasegawa1, Naoko Takahashi, Alistair R R Forrest, Jay W Shin, Yohei Kinoshita, Harukazu Suzuki, Yoshihide Hayashizaki.   

Abstract

The pluripotency of mouse embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) can be maintained by feeder cells, which secrete leukemia inhibitory factor (LIF). We found that feeder cells provide a relatively low concentration (25 unit/ml) of LIF, which is insufficient to maintain the ESCs/iPSCs pluripotency in feeder free conditions. To identify additional factors involved in the maintenance of pluripotency, we carried out a global transcript expression profiling of mouse iPSCs cultured on feeder cells and in feeder-free (LIF-treated) conditions. This identified 17 significantly differentially expressed genes (adjusted p value <0.05) including seven chemokines overexpressed in iPSCs grown on feeder cells. Ectopic expression of these chemokines in iPSCs revealed that CC chemokine ligand 2 (Ccl2) induced the key transcription factor genes for pluripotency, Klf4, Nanog, Sox2, and Tbx3. Furthermore, addition of recombinant Ccl2 protein drastically increased the number of Nanog-green fluorescent protein-positive iPSCs grown in low-LIF feeder free conditions. We further revealed that pluripotency promotion by Ccl2 is mediated by activating the Stat3-pathway followed by Klf4 upregulation. We demonstrated that Ccl2-mediated increased pluripotency is independent of phosphoinositide 3-kinase and mitogen-activated protein kinase pathways and that Tbx3 may be upregulated by Klf4. Overall, Ccl2 cooperatively activates the Stat3-pathway with LIF in feeder-free conditions to maintain pluripotency for ESCs/iPSCs.
Copyright © 2011 AlphaMed Press.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21681859     DOI: 10.1002/stem.673

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  13 in total

Review 1.  Hydrodynamics in Cell Studies.

Authors:  Deborah Huber; Ali Oskooei; Xavier Casadevall I Solvas; Govind V Kaigala
Journal:  Chem Rev       Date:  2018-02-08       Impact factor: 60.622

2.  Genetic variations in monocyte chemoattractant protein-1 and susceptibility to ovarian cancer.

Authors:  Li Li; Jinshan Zhang; Xin Weng; Ge Wen
Journal:  Tumour Biol       Date:  2014-09-19

3.  Deep transcriptome profiling of mammalian stem cells supports a regulatory role for retrotransposons in pluripotency maintenance.

Authors:  Alexandre Fort; Kosuke Hashimoto; Daisuke Yamada; Md Salimullah; Chaman A Keya; Alka Saxena; Alessandro Bonetti; Irina Voineagu; Nicolas Bertin; Anton Kratz; Yukihiko Noro; Chee-Hong Wong; Michiel de Hoon; Robin Andersson; Albin Sandelin; Harukazu Suzuki; Chia-Lin Wei; Haruhiko Koseki; Yuki Hasegawa; Alistair R R Forrest; Piero Carninci
Journal:  Nat Genet       Date:  2014-04-28       Impact factor: 38.330

4.  Proteome array identification of bioactive soluble proteins/peptides in Matrigel: relevance to stem cell responses.

Authors:  Neil C Talbot; Thomas J Caperna
Journal:  Cytotechnology       Date:  2014-04-18       Impact factor: 2.058

Review 5.  Retinoblastoma tumor suppressor functions shared by stem cell and cancer cell strategies.

Authors:  Susumu Kohno; Shunsuke Kitajima; Nobunari Sasaki; Chiaki Takahashi
Journal:  World J Stem Cells       Date:  2016-04-26       Impact factor: 5.326

6.  A draft network of ligand-receptor-mediated multicellular signalling in human.

Authors:  Jordan A Ramilowski; Tatyana Goldberg; Jayson Harshbarger; Edda Kloppmann; Edda Kloppman; Marina Lizio; Venkata P Satagopam; Masayoshi Itoh; Hideya Kawaji; Piero Carninci; Burkhard Rost; Alistair R R Forrest
Journal:  Nat Commun       Date:  2015-07-22       Impact factor: 14.919

7.  CCL2 enhances pluripotency of human induced pluripotent stem cells by activating hypoxia related genes.

Authors:  Yuki Hasegawa; Dave Tang; Naoko Takahashi; Yoshihide Hayashizaki; Alistair R R Forrest; Harukazu Suzuki
Journal:  Sci Rep       Date:  2014-06-24       Impact factor: 4.379

8.  Optimal ratio of transcription factors for somatic cell reprogramming.

Authors:  Go Nagamatsu; Shigeru Saito; Takeo Kosaka; Keiyo Takubo; Taisuke Kinoshita; Mototsugu Oya; Katsuhisa Horimoto; Toshio Suda
Journal:  J Biol Chem       Date:  2012-09-06       Impact factor: 5.157

9.  Growth factor-activated stem cell circuits and stromal signals cooperatively accelerate non-integrated iPSC reprogramming of human myeloid progenitors.

Authors:  Tea Soon Park; Jeffrey S Huo; Ann Peters; C Conover Talbot; Karan Verma; Ludovic Zimmerlin; Ian M Kaplan; Elias T Zambidis
Journal:  PLoS One       Date:  2012-08-08       Impact factor: 3.240

10.  Secretome from senescent melanoma engages the STAT3 pathway to favor reprogramming of naive melanoma towards a tumor-initiating cell phenotype.

Authors:  Mickaël Ohanna; Yann Cheli; Caroline Bonet; Vanessa F Bonazzi; Marylin Allegra; Sandy Giuliano; Karine Bille; Philippe Bahadoran; Damien Giacchero; Jean Philippe Lacour; Glen M Boyle; Nicholas F Hayward; Corine Bertolotto; Robert Ballotti
Journal:  Oncotarget       Date:  2013-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.